证券记录 · 已归档季度
ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
12被追踪持有人
-1Δ持有人
9.43M持有股份
$2.71B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -7.7% ·
股份流向 -0.4% ·
净新建仓位 -8.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +2 | 54.24M | $9.34B | +10 | −7 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | — |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | — | 9.47M | $2.97B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.35M | +27.9% | $962.66M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.35M | +27.9% | $962.66M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 3.08M | +11.7% | $885.48M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 1.00M | +3.6% | $288.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 775.10K | -10.4% | $222.69M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 580.05K | -57.4% | $166.65M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 580.05K | -57.4% | $166.65M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 212.10K | -6.2% | $60.94M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 165.47K | +107.5% | $47.54M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 114.28K | -74.5% | $32.83M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 19 | Geode Capital Management ✦ (被动) | 83.42K | +0.9% | $23.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 56.27K | +37.5% | $16.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 5.50K | +1.6% | $1.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Capital World Investors ✦ | 1.32K | 新增 | $380,398 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Capital World Investors | $380,398 | 0.0% |
已清仓
| Adage Capital Partners | $3.45M | 曾为 0.0% |
| AQR Capital Management | $547,945 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 414 持有人, 78.10M 股份, $8.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 11
O'Neill Julie
Director · 105 股 · $17,196
Aug 11
Murphy Ronan Martin
Director · 67 股 · $11,089
Aug 11
Murray Ciaran
Director · 280 股 · $45,562
Aug 11
Murray Ciaran
Director · 305 股 · $49,950
Aug 11
Murray Ciaran
Director · 1.88K 股 · $309,204
Aug 11
Murray Ciaran
Director · 212 股 · $35,088
Aug 11
O'Neill Julie
Director · 95 股 · $15,458
Aug 11
O'Neill Julie
Director · 642 股 · $105,590
Aug 11
O'Neill Julie
Director · 73 股 · $12,082
Aug 11
Whitaker Anne Clem
Director · 88 股 · $14,319
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Invesco Ltd.
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据